Animal Model Market by Animal Type (Rat, Mice, Guinea Pigs, Rabbits, and Others), Application (Drug Discovery & Development, Basic Research, and Others), and End User (Pharma & Biotech Companies, Academic Research Institutes, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030
The global animal model market was valued at $1,469 million in 2020, and is projected to reach $2,677 million by 2030, registering a CAGR of 6.1% from 2021 to 2030.
The animal in which biological and pathological studies are done & tested is known as an animal model. Animal models are utilized as they have functional similarity to the human body. They are used to study the development & advancement of various diseases and test new treatment methods before conducting human trials. However, there are several animal welfare guidelines that have to be followed while using animal models for experiments. There are different types of animals used as animal models such as rat, mice, guinea pigs, rabbits, and others.
The growth of the animal model market is driven by rise in demand for personalized medicines, increase in development of humanized mouse models, surge in initiatives by government organizations in various academic & research institutions, and increase in number of pharmaceutical R&D activities. In addition, emergence of CRISPR as a powerful technology in the field of biomedical research, increase in need of animal models for production & quality control for therapeutic purpose, rise in use of animal models in biomedical research, toxicology, physiology, cancer research, neurological research, genetic research, & xenotransplantation further boost the growth of the market. Moreover, use of animal model aids in validation & target identification, drug screening & lead optimization, toxicity & safety screening, and in preclinical analyses of drug safety & efficacy, which drive the growth of the market. However, regulations and laws for ethical use of animals in research are expected to restrain the growth of the animal model market. Conversely, growth opportunities in emerging markets are expected to offer lucrative opportunities during the forecast period.
The animal model market is segmented into animal type, application, end user, and region. On the basis of animal type, the market is categorized into rat, mice, guinea pigs, rabbits, and others. By application, the market is divided into drug discovery & development, basic research, and others. The drug discovery & development segment is further segmented by animal type such as rat, mice, guinea pigs, rabbits, and others. The basic research segment is further segmented by animal type such as rat, mice, guinea pigs, rabbits, and others. The others segment is further fragmented by animal type such as rat, mice, guinea pigs, rabbits, and others. By end user, the market is segregated into pharma & biotech companies, academic research institutes, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
By Animal Type
The animal in which biological and pathological studies are done & tested is known as an animal model. Animal models are utilized as they have functional similarity to the human body. They are used to study the development & advancement of various diseases and test new treatment methods before conducting human trials. However, there are several animal welfare guidelines that have to be followed while using animal models for experiments. There are different types of animals used as animal models such as rat, mice, guinea pigs, rabbits, and others.
The growth of the animal model market is driven by rise in demand for personalized medicines, increase in development of humanized mouse models, surge in initiatives by government organizations in various academic & research institutions, and increase in number of pharmaceutical R&D activities. In addition, emergence of CRISPR as a powerful technology in the field of biomedical research, increase in need of animal models for production & quality control for therapeutic purpose, rise in use of animal models in biomedical research, toxicology, physiology, cancer research, neurological research, genetic research, & xenotransplantation further boost the growth of the market. Moreover, use of animal model aids in validation & target identification, drug screening & lead optimization, toxicity & safety screening, and in preclinical analyses of drug safety & efficacy, which drive the growth of the market. However, regulations and laws for ethical use of animals in research are expected to restrain the growth of the animal model market. Conversely, growth opportunities in emerging markets are expected to offer lucrative opportunities during the forecast period.
The animal model market is segmented into animal type, application, end user, and region. On the basis of animal type, the market is categorized into rat, mice, guinea pigs, rabbits, and others. By application, the market is divided into drug discovery & development, basic research, and others. The drug discovery & development segment is further segmented by animal type such as rat, mice, guinea pigs, rabbits, and others. The basic research segment is further segmented by animal type such as rat, mice, guinea pigs, rabbits, and others. The others segment is further fragmented by animal type such as rat, mice, guinea pigs, rabbits, and others. By end user, the market is segregated into pharma & biotech companies, academic research institutes, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
- A comprehensive analysis of four regions is provided to determine the existing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
By Animal Type
- Rat
- Mice
- Guinea Pigs
- Rabbits
- Others
- Drug Discovery & Development
- Rat
- Mice
- Guinea Pigs
- Rabbits
- Others
- Basic Research
- Rat
- Mice
- Guinea Pigs
- Rabbits
- Others
- Others
- Rat
- Mice
- Guinea Pigs
- Rabbits
- Others
- Pharma & Biotech Companies
- Academic Research Institutes
- Others
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Charles River Laboratories International, Inc
- Envigo
- Eurofins Scientific SE
- GenOway S.A.
- Hera BioLabs (Transposagen Biopharmaceuticals)
- JSR Corporation (Crown Bioscience Inc.)
- Ozgene Pty Ltd.
- PerkinElmer, Inc. (Horizon Discovery Group plc.)
- Taconic Biosciences
- The Jackson Laboratory
- PharmaLegacy
- Trans Genic Inc, Ltd
- Cyagen Biosciences
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five force analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Rise in usage of animal models in virology and infectious diseases
3.5.1.2. Increase in adoption of CRISPR technology
3.5.1.3. Upsurge in likelihood of epidemic or pandemic outbreaks
3.5.2. Restraint
3.5.2.1. Regulations and laws for ethical use of animals in research
3.5.3. Opportunity
3.5.3.1. Growth opportunities in emerging markets
3.5.4. Impact analysis
3.6. COVID-19 impact analysis on the animal model market
CHAPTER 4: ANIMAL MODEL MARKET, BY ANIMAL TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Rat
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Mice
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Guinea pigs
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Rabbits
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
4.6. Others
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country
CHAPTER 5: ANIMAL MODEL MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Drug discovery & development
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.2.4. Market size and forecast, by animal type
5.3. Basic research
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market analysis, by country
5.3.4. Market size and forecast, by animal type
5.4. Others
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market analysis, by country
5.4.4. Market size and forecast, by animal type
CHAPTER 6: ANIMAL MODEL MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Pharma & biotech companies
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market analysis, by country
6.3. Academic research institutes
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market analysis, by country
6.4. Others
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market analysis, by country
CHAPTER 7: ANIMAL MODEL MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. animal model market, by animal type
7.2.2.1.2. U.S. animal model market, by application
7.2.2.1.3. U.S. animal model market, by end user
7.2.2.2. Canada
7.2.2.2.1. Canada animal model market, by animal type
7.2.2.2.2. Canada animal model market, by application
7.2.2.2.3. Canada animal model market, by end user
7.2.2.3. Mexico
7.2.2.3.1. Mexico animal model market, by animal type
7.2.2.3.2. Mexico animal model market, by application
7.2.2.3.3. Mexico animal model market, by end user
7.2.3. North America market size and forecast, by animal type
7.2.4. North America market size and forecast, by application
7.2.5. North America market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country
7.3.2.1. Germany
7.3.2.1.1. Germany animal model market, by animal type
7.3.2.1.2. Germany animal model market, by application
7.3.2.1.3. Germany animal model market, by end user
7.3.2.2. France
7.3.2.2.1. France animal model market, by animal type
7.3.2.2.2. France animal model market, by application
7.3.2.2.3. France animal model market, by end user
7.3.2.3. UK
7.3.2.3.1. UK animal model market, by animal type
7.3.2.3.2. UK animal model market, by application
7.3.2.3.3. UK animal model market, by end user
7.3.2.4. Italy
7.3.2.4.1. Italy animal model market, by animal type
7.3.2.4.2. Italy animal model market, by application
7.3.2.4.3. Italy animal model market, by end user
7.3.2.5. Spain
7.3.2.5.1. Spain animal model market, by animal type
7.3.2.5.2. Spain animal model market, by application
7.3.2.5.3. Spain animal model market, by end user
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe animal model market, by animal type
7.3.2.6.2. Rest of Europe animal model market, by application
7.3.2.6.3. Rest of Europe animal model market, by end user
7.3.3. Europe market size and forecast, by animal type
7.3.4. Europe market size and forecast, by application
7.3.5. Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country
7.4.2.1. Japan
7.4.2.1.1. Japan animal model market, by animal type
7.4.2.1.2. Japan animal model market, by application
7.4.2.1.3. Japan animal model market, by end user
7.4.2.2. China
7.4.2.2.1. China animal model market, by animal type
7.4.2.2.2. China animal model market, by application
7.4.2.2.3. China animal model market, by end user
7.4.2.3. Australia
7.4.2.3.1. Australia animal model market, by animal type
7.4.2.3.2. Australia animal model market, by application
7.4.2.3.3. Australia animal model market, by end user
7.4.2.4. India
7.4.2.4.1. India animal model market, by animal type
7.4.2.4.2. India animal model market, by application
7.4.2.4.3. India animal model market, by end user
7.4.2.5. South Korea
7.4.2.5.1. South Korea animal model market, by animal type
7.4.2.5.2. South Korea animal model market, by application
7.4.2.5.3. South Korea animal model market, by end user
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific animal model market, by animal type
7.4.2.6.2. Rest of Asia-Pacific animal model market, by application
7.4.2.6.3. Rest of Asia-Pacific animal model market, by end user
7.4.3. Asia-Pacific market size and forecast, by animal type
7.4.4. Asia-Pacific market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil animal model market, by animal type
7.5.2.1.2. Brazil animal model market, by application
7.5.2.1.3. Brazil animal model market, by end user
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia animal model market, by animal type
7.5.2.2.2. Saudi Arabia animal model market, by application
7.5.2.2.3. Saudi Arabia animal model market, by end user
7.5.2.3. South Africa
7.5.2.3.1. South Africa animal model market, by animal type
7.5.2.3.2. South Africa animal model market, by application
7.5.2.3.3. South Africa animal model market, by end user
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA animal model market, by animal type
7.5.2.4.2. Rest of LAMEA animal model market, by application
7.5.2.4.3. Rest of LAMEA animal model market, by end user
7.5.3. LAMEA market size and forecast, by animal type
7.5.4. LAMEA market size and forecast, by application
7.5.5. LAMEA market size and forecast, by end user
CHAPTER 8: COMPANY PROFILES
8.1. Charles River Laboratories International, Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.2. Envigo
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Key strategic moves and developments
8.3. Eurofins Scientific SE
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.4. GenOway S.A.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. Hera BioLabs (Transposagen Biopharmaceuticals)
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.6. JSR Corporation (Crown Bioscience Inc.)
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. Ozgene Pty Ltd.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.8. PerkinElmer, Inc. (Horizon Discovery Group plc.)
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.9. Taconic Biosciences
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Key strategic moves and developments
8.10. The Jackson Laboratory
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five force analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Rise in usage of animal models in virology and infectious diseases
3.5.1.2. Increase in adoption of CRISPR technology
3.5.1.3. Upsurge in likelihood of epidemic or pandemic outbreaks
3.5.2. Restraint
3.5.2.1. Regulations and laws for ethical use of animals in research
3.5.3. Opportunity
3.5.3.1. Growth opportunities in emerging markets
3.5.4. Impact analysis
3.6. COVID-19 impact analysis on the animal model market
CHAPTER 4: ANIMAL MODEL MARKET, BY ANIMAL TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Rat
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Mice
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Guinea pigs
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Rabbits
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
4.6. Others
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country
CHAPTER 5: ANIMAL MODEL MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Drug discovery & development
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.2.4. Market size and forecast, by animal type
5.3. Basic research
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market analysis, by country
5.3.4. Market size and forecast, by animal type
5.4. Others
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market analysis, by country
5.4.4. Market size and forecast, by animal type
CHAPTER 6: ANIMAL MODEL MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Pharma & biotech companies
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market analysis, by country
6.3. Academic research institutes
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market analysis, by country
6.4. Others
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market analysis, by country
CHAPTER 7: ANIMAL MODEL MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. animal model market, by animal type
7.2.2.1.2. U.S. animal model market, by application
7.2.2.1.3. U.S. animal model market, by end user
7.2.2.2. Canada
7.2.2.2.1. Canada animal model market, by animal type
7.2.2.2.2. Canada animal model market, by application
7.2.2.2.3. Canada animal model market, by end user
7.2.2.3. Mexico
7.2.2.3.1. Mexico animal model market, by animal type
7.2.2.3.2. Mexico animal model market, by application
7.2.2.3.3. Mexico animal model market, by end user
7.2.3. North America market size and forecast, by animal type
7.2.4. North America market size and forecast, by application
7.2.5. North America market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country
7.3.2.1. Germany
7.3.2.1.1. Germany animal model market, by animal type
7.3.2.1.2. Germany animal model market, by application
7.3.2.1.3. Germany animal model market, by end user
7.3.2.2. France
7.3.2.2.1. France animal model market, by animal type
7.3.2.2.2. France animal model market, by application
7.3.2.2.3. France animal model market, by end user
7.3.2.3. UK
7.3.2.3.1. UK animal model market, by animal type
7.3.2.3.2. UK animal model market, by application
7.3.2.3.3. UK animal model market, by end user
7.3.2.4. Italy
7.3.2.4.1. Italy animal model market, by animal type
7.3.2.4.2. Italy animal model market, by application
7.3.2.4.3. Italy animal model market, by end user
7.3.2.5. Spain
7.3.2.5.1. Spain animal model market, by animal type
7.3.2.5.2. Spain animal model market, by application
7.3.2.5.3. Spain animal model market, by end user
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe animal model market, by animal type
7.3.2.6.2. Rest of Europe animal model market, by application
7.3.2.6.3. Rest of Europe animal model market, by end user
7.3.3. Europe market size and forecast, by animal type
7.3.4. Europe market size and forecast, by application
7.3.5. Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country
7.4.2.1. Japan
7.4.2.1.1. Japan animal model market, by animal type
7.4.2.1.2. Japan animal model market, by application
7.4.2.1.3. Japan animal model market, by end user
7.4.2.2. China
7.4.2.2.1. China animal model market, by animal type
7.4.2.2.2. China animal model market, by application
7.4.2.2.3. China animal model market, by end user
7.4.2.3. Australia
7.4.2.3.1. Australia animal model market, by animal type
7.4.2.3.2. Australia animal model market, by application
7.4.2.3.3. Australia animal model market, by end user
7.4.2.4. India
7.4.2.4.1. India animal model market, by animal type
7.4.2.4.2. India animal model market, by application
7.4.2.4.3. India animal model market, by end user
7.4.2.5. South Korea
7.4.2.5.1. South Korea animal model market, by animal type
7.4.2.5.2. South Korea animal model market, by application
7.4.2.5.3. South Korea animal model market, by end user
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific animal model market, by animal type
7.4.2.6.2. Rest of Asia-Pacific animal model market, by application
7.4.2.6.3. Rest of Asia-Pacific animal model market, by end user
7.4.3. Asia-Pacific market size and forecast, by animal type
7.4.4. Asia-Pacific market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil animal model market, by animal type
7.5.2.1.2. Brazil animal model market, by application
7.5.2.1.3. Brazil animal model market, by end user
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia animal model market, by animal type
7.5.2.2.2. Saudi Arabia animal model market, by application
7.5.2.2.3. Saudi Arabia animal model market, by end user
7.5.2.3. South Africa
7.5.2.3.1. South Africa animal model market, by animal type
7.5.2.3.2. South Africa animal model market, by application
7.5.2.3.3. South Africa animal model market, by end user
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA animal model market, by animal type
7.5.2.4.2. Rest of LAMEA animal model market, by application
7.5.2.4.3. Rest of LAMEA animal model market, by end user
7.5.3. LAMEA market size and forecast, by animal type
7.5.4. LAMEA market size and forecast, by application
7.5.5. LAMEA market size and forecast, by end user
CHAPTER 8: COMPANY PROFILES
8.1. Charles River Laboratories International, Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.2. Envigo
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Key strategic moves and developments
8.3. Eurofins Scientific SE
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.4. GenOway S.A.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. Hera BioLabs (Transposagen Biopharmaceuticals)
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.6. JSR Corporation (Crown Bioscience Inc.)
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. Ozgene Pty Ltd.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.8. PerkinElmer, Inc. (Horizon Discovery Group plc.)
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.9. Taconic Biosciences
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Key strategic moves and developments
8.10. The Jackson Laboratory
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
LIST OF TABLES
TABLE 01. ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 02. RAT ANIMAL MODEL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 03. MICE ANIMAL MODEL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 04. GUINEA PIGS ANIMAL MODEL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 05. RABBITS ANIMAL MODEL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 06. OTHERS ANIMAL MODEL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 07. ANIMAL MODEL MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 08. ANIMAL MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2020-2030 ($MILLION)
TABLE 09. ANIMAL MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 10. ANIMAL MODEL MARKET FOR BASIC RESEARCH, BY REGION, 2020-2030 ($MILLION)
TABLE 11. ANIMAL MODEL MARKET FOR BASIC RESEARCH, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 12. ANIMAL MODEL MARKET FOR OTHER APPLICATIONS, BY REGION, 2020-2030 ($MILLION)
TABLE 13. ANIMAL MODEL MARKET FOR BASIC RESEARCH, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 14. ANIMAL MODEL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 15. ANIMAL MODEL MARKET FOR PHARMA & BIOTECH COMPANIES, BY REGION, 2020-2030 ($MILLION)
TABLE 16. ANIMAL MODEL MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2020-2030 ($MILLION)
TABLE 17. ANIMAL MODEL MARKET FOR OTHER END USER, BY REGION, 2020-2030 ($MILLION)
TABLE 18. ANIMAL MODEL MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 19. NORTH AMERICA ANIMAL MODEL MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 20. U.S. ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 21. U.S. ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 22. U.S. ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 23. CANADA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 24. CANADA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 25. CANADA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 26. MEXICO ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 27. MEXICO ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 28. MEXICO ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 29. NORTH AMERICA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 30. NORTH AMERICA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 31. NORTH AMERICA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 32. EUROPE ANIMAL MODEL MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 33. GERMANY ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 34. GERMANY ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 35. GERMANY ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 36. FRANCE ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 37. FRANCE ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 38. FRANCE ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 39. UK ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 40. UK ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 41. UK ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 42. ITALY ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 43. ITALY ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 44. ITALY ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 45. SPAIN ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 46. SPAIN ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 47. SPAIN ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 48. REST OF EUROPE ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 49. REST OF EUROPE ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 50. REST OF EUROPE ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 51. EUROPE ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 52. EUROPE ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 53. EUROPE ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 54. ASIA-PACIFIC ANIMAL MODEL MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 55. JAPAN ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 56. JAPAN ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 57. JAPAN ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 58. CHINA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 59. CHINA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 60. CHINA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 61. AUSTRALIA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 62. AUSTRALIA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 63. AUSTRALIA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 64. INDIA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 65. INDIA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 66. INDIA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 67. SOUTH KOREA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 68. SOUTH KOREA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 69. SOUTH KOREA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 73. ASIA-PACIFIC ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 74. ASIA-PACIFIC ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 75. ASIA-PACIFIC ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 76. LAMEA ANIMAL MODEL MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 77. BRAZIL ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 78. BRAZIL ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 79. BRAZIL ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 80. SAUDI ARABIA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 81. SAUDI ARABIA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 82. SAUDI ARABIA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 83. SOUTH AFRICA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 84. SOUTH AFRICA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 85. SOUTH AFRICA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 86. REST OF LAMEA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 87. REST OF LAMEA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 88. REST OF LAMEA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 89. LAMEA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 90. LAMEA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 91. LAMEA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 92. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT
TABLE 93. CHARLES RIVER LABORATORIES INTERNATIONAL: OPERATING SEGMENTS
TABLE 94. CHARLES RIVER LABORATORIES INTERNATIONAL: PRODUCT PORTFOLIO
TABLE 95. ENVIGO: COMPANY SNAPSHOT
TABLE 96. ENVIGO: OERATING SEGMENT
TABLE 97. ENVIGO: PRODUCT PORTFOLIO
TABLE 98. ENVIGO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 99. EUROFINS: COMPANY SNAPSHOT
TABLE 100. EUROFINS: OPERATING SEGMENTS
TABLE 101. EUROFINS: PRODUCT PORTFOLIO
TABLE 102. GENOWAY S.A.: COMPANY SNAPSHOT
TABLE 103. GENOWAY S.A.: OERATING SEGMENT
TABLE 104. GENOWAY S.A.: PRODUCT PORTFOLIO
TABLE 105. GENOWAY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 106. HERA BIOLABS: COMPANY SNAPSHOT
TABLE 107. HERA BIOLABS: OERATING SEGMENT
TABLE 108. HERA BIOLABS: PRODUCT PORTFOLIO
TABLE 109. JSR CORPORATION: COMPANY SNAPSHOT
TABLE 110. JSR CORPORATION: OERATING SEGMENT
TABLE 111. JSR CORPORATION: PRODUCT PORTFOLIO
TABLE 112. CROWNBIO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 113. OZGENE PTY LTD.: COMPANY SNAPSHOT
TABLE 114. OZGENE PTY LTD.: OPERATING SEGMENTS
TABLE 115. OZGENE PTY LTD.: PRODUCT PORTFOLIO
TABLE 116. PERKINELMER, INC.: COMPANY SNAPSHOT
TABLE 117. PERKINELMER, INC.: OPERATING SEGMENTS
TABLE 118. PERKINELMER, INC.: PRODUCT PORTFOLIO
TABLE 119. TACONIC BIOSCIENCES: COMPANY SNAPSHOT
TABLE 120. TACONIC BIOSCIENCES: OPERATING SEGMENTS
TABLE 121. TACONIC BIOSCIENCES: PRODUCT PORTFOLIO
TABLE 122. TACONIC BIOSCIENCES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 123. THE JACKSON LABORATORY: COMPANY SNAPSHOT
TABLE 124. THE JACKSON LABORATORY: OPERATING SEGMENT
TABLE 125. THE JACKSON LABORATORY.: PRODUCT PORTFOLIO
TABLE 126. THE JACKSON LABORATORY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 01. ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 02. RAT ANIMAL MODEL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 03. MICE ANIMAL MODEL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 04. GUINEA PIGS ANIMAL MODEL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 05. RABBITS ANIMAL MODEL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 06. OTHERS ANIMAL MODEL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 07. ANIMAL MODEL MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 08. ANIMAL MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2020-2030 ($MILLION)
TABLE 09. ANIMAL MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 10. ANIMAL MODEL MARKET FOR BASIC RESEARCH, BY REGION, 2020-2030 ($MILLION)
TABLE 11. ANIMAL MODEL MARKET FOR BASIC RESEARCH, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 12. ANIMAL MODEL MARKET FOR OTHER APPLICATIONS, BY REGION, 2020-2030 ($MILLION)
TABLE 13. ANIMAL MODEL MARKET FOR BASIC RESEARCH, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 14. ANIMAL MODEL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 15. ANIMAL MODEL MARKET FOR PHARMA & BIOTECH COMPANIES, BY REGION, 2020-2030 ($MILLION)
TABLE 16. ANIMAL MODEL MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2020-2030 ($MILLION)
TABLE 17. ANIMAL MODEL MARKET FOR OTHER END USER, BY REGION, 2020-2030 ($MILLION)
TABLE 18. ANIMAL MODEL MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 19. NORTH AMERICA ANIMAL MODEL MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 20. U.S. ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 21. U.S. ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 22. U.S. ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 23. CANADA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 24. CANADA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 25. CANADA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 26. MEXICO ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 27. MEXICO ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 28. MEXICO ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 29. NORTH AMERICA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 30. NORTH AMERICA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 31. NORTH AMERICA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 32. EUROPE ANIMAL MODEL MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 33. GERMANY ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 34. GERMANY ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 35. GERMANY ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 36. FRANCE ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 37. FRANCE ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 38. FRANCE ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 39. UK ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 40. UK ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 41. UK ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 42. ITALY ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 43. ITALY ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 44. ITALY ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 45. SPAIN ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 46. SPAIN ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 47. SPAIN ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 48. REST OF EUROPE ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 49. REST OF EUROPE ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 50. REST OF EUROPE ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 51. EUROPE ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 52. EUROPE ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 53. EUROPE ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 54. ASIA-PACIFIC ANIMAL MODEL MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 55. JAPAN ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 56. JAPAN ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 57. JAPAN ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 58. CHINA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 59. CHINA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 60. CHINA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 61. AUSTRALIA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 62. AUSTRALIA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 63. AUSTRALIA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 64. INDIA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 65. INDIA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 66. INDIA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 67. SOUTH KOREA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 68. SOUTH KOREA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 69. SOUTH KOREA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 73. ASIA-PACIFIC ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 74. ASIA-PACIFIC ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 75. ASIA-PACIFIC ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 76. LAMEA ANIMAL MODEL MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 77. BRAZIL ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 78. BRAZIL ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 79. BRAZIL ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 80. SAUDI ARABIA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 81. SAUDI ARABIA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 82. SAUDI ARABIA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 83. SOUTH AFRICA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 84. SOUTH AFRICA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 85. SOUTH AFRICA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 86. REST OF LAMEA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 87. REST OF LAMEA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 88. REST OF LAMEA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 89. LAMEA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 90. LAMEA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 91. LAMEA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 92. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT
TABLE 93. CHARLES RIVER LABORATORIES INTERNATIONAL: OPERATING SEGMENTS
TABLE 94. CHARLES RIVER LABORATORIES INTERNATIONAL: PRODUCT PORTFOLIO
TABLE 95. ENVIGO: COMPANY SNAPSHOT
TABLE 96. ENVIGO: OERATING SEGMENT
TABLE 97. ENVIGO: PRODUCT PORTFOLIO
TABLE 98. ENVIGO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 99. EUROFINS: COMPANY SNAPSHOT
TABLE 100. EUROFINS: OPERATING SEGMENTS
TABLE 101. EUROFINS: PRODUCT PORTFOLIO
TABLE 102. GENOWAY S.A.: COMPANY SNAPSHOT
TABLE 103. GENOWAY S.A.: OERATING SEGMENT
TABLE 104. GENOWAY S.A.: PRODUCT PORTFOLIO
TABLE 105. GENOWAY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 106. HERA BIOLABS: COMPANY SNAPSHOT
TABLE 107. HERA BIOLABS: OERATING SEGMENT
TABLE 108. HERA BIOLABS: PRODUCT PORTFOLIO
TABLE 109. JSR CORPORATION: COMPANY SNAPSHOT
TABLE 110. JSR CORPORATION: OERATING SEGMENT
TABLE 111. JSR CORPORATION: PRODUCT PORTFOLIO
TABLE 112. CROWNBIO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 113. OZGENE PTY LTD.: COMPANY SNAPSHOT
TABLE 114. OZGENE PTY LTD.: OPERATING SEGMENTS
TABLE 115. OZGENE PTY LTD.: PRODUCT PORTFOLIO
TABLE 116. PERKINELMER, INC.: COMPANY SNAPSHOT
TABLE 117. PERKINELMER, INC.: OPERATING SEGMENTS
TABLE 118. PERKINELMER, INC.: PRODUCT PORTFOLIO
TABLE 119. TACONIC BIOSCIENCES: COMPANY SNAPSHOT
TABLE 120. TACONIC BIOSCIENCES: OPERATING SEGMENTS
TABLE 121. TACONIC BIOSCIENCES: PRODUCT PORTFOLIO
TABLE 122. TACONIC BIOSCIENCES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 123. THE JACKSON LABORATORY: COMPANY SNAPSHOT
TABLE 124. THE JACKSON LABORATORY: OPERATING SEGMENT
TABLE 125. THE JACKSON LABORATORY.: PRODUCT PORTFOLIO
TABLE 126. THE JACKSON LABORATORY: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 01. ANIMAL MODEL MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2018-2021
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2021
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2018-2021
FIGURE 06. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. HIGH THREAT OF SUBSTITUTES
FIGURE 09. HIGH THREAT OF NEW ENTRANTS
FIGURE 10. MODERATE INTENSITY OF RIVALRY
FIGURE 11. TOP PLAYER POSITIONING, 2020
FIGURE 12. IMPACT ANALYSIS
FIGURE 13. COMPARATIVE ANALYSIS OF RAT ANIMAL MODEL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14. COMPARATIVE ANALYSIS OF MICE ANIMAL MODEL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 15. COMPARATIVE ANALYSIS OF GUINEA PIGS ANIMAL MODEL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 16. COMPARATIVE ANALYSIS OF RABBITS ANIMAL MODEL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 17. COMPARATIVE ANALYSIS OF OTHERS ANIMAL MODEL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 18. COMPARATIVE ANALYSIS OF ANIMAL MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 19. COMPARATIVE ANALYSIS OF ANIMAL MODEL MARKET FOR BASIC RESEARCH, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 20. COMPARATIVE ANALYSIS OF ANIMAL MODEL MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 21. COMPARATIVE ANALYSIS OF ANIMAL MODEL MARKET FOR PHARMA & BIOTECH COMPANIES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 22. COMPARATIVE ANALYSIS OF ANIMAL MODEL MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 23. COMPARATIVE ANALYSIS OF ANIMAL MODEL MARKET FOR OTHER END USER, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 24. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: NET SALES, 2018–2020 ($MILLION)
FIGURE 25. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 26. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 27. EUROFINS: NET SALES, 2018–2020 ($MILLION)
FIGURE 28. EUROFINS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 29. GENOWAY S.A.: NET SALES, 2018–2020 ($MILLION)
FIGURE 30. GENOWAY S.A.: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 31. JSR CORPORATION: NET SALES, 2018–2020 ($MILLION)
FIGURE 32. JSR CORPORATION: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 33. PERKINELMER, INC.: NET SALES, 2018–2020 ($MILLION)
FIGURE 34. PERKINELMER, INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 35. PERKINELMER, INC.: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 36. THE JACKSON LABORATORY: NET SALES, 2017–2019 ($MILLION)
FIGURE 01. ANIMAL MODEL MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2018-2021
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2021
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2018-2021
FIGURE 06. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. HIGH THREAT OF SUBSTITUTES
FIGURE 09. HIGH THREAT OF NEW ENTRANTS
FIGURE 10. MODERATE INTENSITY OF RIVALRY
FIGURE 11. TOP PLAYER POSITIONING, 2020
FIGURE 12. IMPACT ANALYSIS
FIGURE 13. COMPARATIVE ANALYSIS OF RAT ANIMAL MODEL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14. COMPARATIVE ANALYSIS OF MICE ANIMAL MODEL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 15. COMPARATIVE ANALYSIS OF GUINEA PIGS ANIMAL MODEL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 16. COMPARATIVE ANALYSIS OF RABBITS ANIMAL MODEL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 17. COMPARATIVE ANALYSIS OF OTHERS ANIMAL MODEL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 18. COMPARATIVE ANALYSIS OF ANIMAL MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 19. COMPARATIVE ANALYSIS OF ANIMAL MODEL MARKET FOR BASIC RESEARCH, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 20. COMPARATIVE ANALYSIS OF ANIMAL MODEL MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 21. COMPARATIVE ANALYSIS OF ANIMAL MODEL MARKET FOR PHARMA & BIOTECH COMPANIES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 22. COMPARATIVE ANALYSIS OF ANIMAL MODEL MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 23. COMPARATIVE ANALYSIS OF ANIMAL MODEL MARKET FOR OTHER END USER, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 24. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: NET SALES, 2018–2020 ($MILLION)
FIGURE 25. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 26. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 27. EUROFINS: NET SALES, 2018–2020 ($MILLION)
FIGURE 28. EUROFINS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 29. GENOWAY S.A.: NET SALES, 2018–2020 ($MILLION)
FIGURE 30. GENOWAY S.A.: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 31. JSR CORPORATION: NET SALES, 2018–2020 ($MILLION)
FIGURE 32. JSR CORPORATION: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 33. PERKINELMER, INC.: NET SALES, 2018–2020 ($MILLION)
FIGURE 34. PERKINELMER, INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 35. PERKINELMER, INC.: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 36. THE JACKSON LABORATORY: NET SALES, 2017–2019 ($MILLION)
